Treating Pulmonary Fibrosis with Non-Viral Gene Therapy: From Bench to Bedside

Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive lung disease characterized by irreversible lung scarring, which achieves almost 80% five-year mortality rate. Undeniably, commercially available pharmaceuticals, such as pirfenidone and nintedanib, exhibit certain effects on improving the...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Teng, Gao, Jia, Cai, Long, Xie, Hao, Wang, Yuhan, Wang, Yi, Zhou, Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9027953/
https://www.ncbi.nlm.nih.gov/pubmed/35456646
http://dx.doi.org/10.3390/pharmaceutics14040813

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9027953/
https://www.ncbi.nlm.nih.gov/pubmed/35456646
http://dx.doi.org/10.3390/pharmaceutics14040813

Ejemplares similares